SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-05-172314
Filing Date
2005-08-22
Accepted
2005-08-22 14:16:20
Documents
8
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-Q d10qa.htm 10-Q/A 22427
2 CO-PROMOTION AGREEMENT dex1050.htm EX-10.50 189975
3 CERTIFICATION BY CEO dex311.htm EX-31.1 9958
4 CERTIFICATION BY CFO dex312.htm EX-31.2 9978
5 GRAPHIC g78877image001.jpg GRAPHIC 101126
6 GRAPHIC g78877image002.jpg GRAPHIC 31144
7 GRAPHIC g78877image003.jpg GRAPHIC 34959
8 GRAPHIC g78877image004.jpg GRAPHIC 127106
  Complete submission text file 0001193125-05-172314.txt   639947
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-23265 | Film No.: 051040594
SIC: 2834 Pharmaceutical Preparations